Nexiclon Xr Tablet, Extended Release
Product Images NDC 71511-503

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nexiclon Xr (NDC 71511-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rosemont Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nexiclon-30.jpg (Image)

Each tablet of Nexiclon XR contains 0.17 mg of Clonidine base, equivalent to 0.2 mg of Clonidine Hydrochloride. The dosage information is mentioned in the prescribing information. The tablets should be stored between 20°C to 25°C. The container should be light-resistant and kept out of reach of children. The NDC number for Nexiclon XR is 71511-503-30, and it is manufactured by Athena Bioscience. This drug is prescribed only and comes with a child-resistant closure.*

FDA Label Image

Molecularstructure (Nexiclon Clonidine Extended Release Tablet 1)

FDA Label Image

Figure1 (Nexiclon Clonidine Extended Release Tablet 2)

FDA Label Image

Figure2 (Nexiclon Clonidine Extended Release Tablet 3)

The text is about blood pressure readings taken at different time points when a medication was administered. The medication has two formulations, one extended-release (ER) and one taken twice-daily (BID IR). The readings are given for both systolic and diastolic blood pressure. Unfortunately, some of the values are not readable (1009).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.